Medium- and long-term results of valve bioprostheses

Introduction: The use of cardiac bioprostheses is constantly growing. Thanks to their hemodynamic characteristics, longevity and non-use of anticoagulants, bioprostheses have become the alternative of choice for patients of all ages.The aim of this work was to describe the profile of patients who have had bioprosthesis valve replacement.Materials and methods: This was a retrospective, multicentric, descriptive, cross-sectional study conducted between September 2017 and December 2021.Results: This study included 106 patients operated on for valve replacement with a bioprosthesis regardless of its position. The mean age was 68 years, with an estimated 9% aged between 17 and 45 years. Follow-up echocardiography revealed a good hemodynamic profile of the bioprostheses implanted in 90.9% of cases, 4 stenosing bioprostheses and two leaky prostheses (3%). Conclusion: Bioprostheses offer a satisfactory quality of life, with promising results in terms of durability and functionality. However, further work is needed to ensure long-term evolution in this young population.

Autorentext

Dr. SOUMER Khédija, tendo completado os meus estudos médicos na Faculdade de Medicina de Tunes, Universidade el Manar de Tunes, e exercendo a sua atividade como assistente de cirurgia cardiovascular, desde janeiro de 2016, no serviço de cirurgia cardiovascular do Hospital Abderrahmen Mami, Ariana, Tunísia.